Metabolic Reprogramming of Castration-Resistant Prostate Cancer Cells as a Response to Chemotherapy

Prostate cancer at the castration-resistant stage (CRPC) is a leading cause of death among men due to resistance to anticancer treatments, including chemotherapy. We set up an in vitro model of therapy-induced cancer repopulation and acquired cell resistance (CRAC) on etoposide-treated CRPC PC3 cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrella, Greta, Corsi, Francesca, Ciufolini, Giorgia, Germini, Sveva, Capradossi, Francesco, Pelliccia, Andrea, Torino, Francesco, Ghibelli, Lina, Cicero, Daniel Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865398/
https://www.ncbi.nlm.nih.gov/pubmed/36676990
http://dx.doi.org/10.3390/metabo13010065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865398/
https://www.ncbi.nlm.nih.gov/pubmed/36676990
http://dx.doi.org/10.3390/metabo13010065

Ejemplares similares